A clinical study to evaluate the effect of Pramehhara Kwatha in the management of Madhumeha w.s.r. to Type II Diabetes Mellitus

Principal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Subjects suffering from the complications of diabetes mellitus i.e. Diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment.
•Patients having major medical illness like cancer, concurrent infection like tuberculosis.
•Patients with uncontrolled hypertension.
•Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.
•Renal dysfunction (defined by eGFR < 60ml/min calculated by MDRD calculator).
•Subjects who have completed participation in any other clinical trial during the past 3 months.
•Subjects with haemoglobin percentage < 9 gm% for males and < 8gm% for females.
•Subjects with concurrent hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit)
•Uncontrolled acute pulmonary dysfunction requiring inhalational or systemic steroids.
•Pregnant/ lactating women.
•Subjects on systemic or oral steroids, oral contraceptives pills or estrogen replacement therapy.

发起方